DE69634647D1 - Cyclische Nitrone und pharmazeutische Mittel die sie enthalten - Google Patents

Cyclische Nitrone und pharmazeutische Mittel die sie enthalten

Info

Publication number
DE69634647D1
DE69634647D1 DE69634647T DE69634647T DE69634647D1 DE 69634647 D1 DE69634647 D1 DE 69634647D1 DE 69634647 T DE69634647 T DE 69634647T DE 69634647 T DE69634647 T DE 69634647T DE 69634647 D1 DE69634647 D1 DE 69634647D1
Authority
DE
Germany
Prior art keywords
pharmaceutical agents
agents containing
cyclic nitrones
nitrones
cyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69634647T
Other languages
English (en)
Other versions
DE69634647T2 (de
Inventor
Craig E Thomas
Thomas L Fevig
Stephen M Bowen
Robert A Farr
Albert A Carr
David A Janovick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Publication of DE69634647D1 publication Critical patent/DE69634647D1/de
Application granted granted Critical
Publication of DE69634647T2 publication Critical patent/DE69634647T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69634647T 1995-09-11 1996-08-15 Cyclische Nitrone und pharmazeutische Mittel die sie enthalten Expired - Fee Related DE69634647T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US355195P 1995-09-11 1995-09-11
US3551P 1995-09-11

Publications (2)

Publication Number Publication Date
DE69634647D1 true DE69634647D1 (de) 2005-05-25
DE69634647T2 DE69634647T2 (de) 2006-03-02

Family

ID=21706397

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69625701T Expired - Fee Related DE69625701T2 (de) 1995-09-11 1996-08-15 Cyclische nitrone und pharmazeutische zusammensetzungen die sie enthalten
DE69634647T Expired - Fee Related DE69634647T2 (de) 1995-09-11 1996-08-15 Cyclische Nitrone und pharmazeutische Mittel die sie enthalten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69625701T Expired - Fee Related DE69625701T2 (de) 1995-09-11 1996-08-15 Cyclische nitrone und pharmazeutische zusammensetzungen die sie enthalten

Country Status (21)

Country Link
US (1) US5962469A (de)
EP (1) EP0863878B1 (de)
JP (1) JPH11512427A (de)
KR (1) KR100512675B1 (de)
CN (3) CN1500787A (de)
AR (1) AR004950A1 (de)
AT (2) ATE230731T1 (de)
AU (1) AU701989B2 (de)
CA (1) CA2231812C (de)
DE (2) DE69625701T2 (de)
DK (2) DK1288203T3 (de)
ES (2) ES2239194T3 (de)
HU (1) HUP9803028A3 (de)
IL (1) IL123345A (de)
MX (1) MX9801892A (de)
NO (1) NO311357B1 (de)
NZ (1) NZ316288A (de)
PT (2) PT1288203E (de)
TW (1) TW337520B (de)
WO (1) WO1997010218A1 (de)
ZA (1) ZA967514B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA99255B (en) * 1998-01-16 1999-07-14 Centaur Pharmaceuticals Inc Thiopene nitrone compounds.
EP1147113B1 (de) * 1999-01-19 2006-06-07 Neurosearch A/S Kondensierte heterocyclische verbindungen und ihre verwendung zur behandlung von neurodegenerativen erkrankungen
CN100513395C (zh) * 2006-04-17 2009-07-15 中国科学院化学研究所 一种制备多羟基环状硝酮的方法
CN101565453B (zh) * 2008-04-22 2011-12-21 中国科学院化学研究所 具有捕获自由基功能的硝酮类化合物及其制备方法与应用
ES2395803B1 (es) * 2011-08-01 2013-12-19 Consejo Superior De Investigaciones Científicas (Csic) - 80% Quinolilnitronas
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
US10660851B2 (en) 2015-01-02 2020-05-26 Rxos Medical Polyfunctional radical scavenger hydrogel formulation
CN105985389B (zh) * 2015-03-06 2019-03-19 北京大学 苯乙醇苷类似物及其合成方法和应用
ES2799705T3 (es) * 2016-02-08 2020-12-21 Lunaphore Tech Sa Procedimientos de multiplexación cíclica de muestras y obtención de imágenes in situ

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35112A (en) * 1862-04-29 Improvement in head-rests for car-seats
US3044930A (en) * 1960-12-08 1962-07-17 Phillips Petroleum Co N-oxides of heterocyclic nitrogen compounds as bird and rodent repellents
US3796715A (en) * 1967-08-30 1974-03-12 Hoffmann La Roche 8-alkoxy-3,4-dihydroisoquinolines
SE368009B (de) * 1971-09-16 1974-06-17 Kabi Ab
US4123543A (en) * 1971-09-16 1978-10-31 Ab Kabi Derivatives of substituted indoline lactans with effect on the central nervous system
US4117144A (en) * 1971-09-16 1978-09-26 Ab Kabi Derivatives of substituted isoindolines with effect on the central nervous system
JPS6363851A (ja) * 1986-09-05 1988-03-22 孫七瓦工業株式会社 瓦の葺設方法
DE69012138T2 (de) * 1989-10-17 1995-04-06 Oklahoma Med Res Found Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten.
ATE209908T1 (de) * 1991-06-18 2001-12-15 Oklahoma Med Res Found RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
US5292746A (en) * 1991-09-12 1994-03-08 Merrell Dow Pharmaceuticals Inc. Cyclic nitrones, pharmaceutical compositions thereof and their use in treating shock
AU652662B2 (en) * 1991-09-12 1994-09-01 Aventis Inc. Cyclic nitrones
US5405967A (en) * 1993-10-22 1995-04-11 Oklahoma Medical Research Foundation Spin-trap molecules 2-trifluoromethyl- of 5,5-dimethyl-1-dyrroline-N-oxide
US5455272A (en) * 1993-10-22 1995-10-03 Oklahoma Medical Research Foundation Spin trap nitronyl hindered phenols
AU8051894A (en) * 1993-10-25 1995-05-22 Oklahoma Medical Research Foundation Novel phosphorus-containing spin-trap compositions
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions

Also Published As

Publication number Publication date
CN1500779A (zh) 2004-06-02
WO1997010218A1 (en) 1997-03-20
TW337520B (en) 1998-08-01
AU6848696A (en) 1997-04-01
CN1500787A (zh) 2004-06-02
IL123345A (en) 2003-07-31
NO981054L (no) 1998-03-10
CA2231812C (en) 2002-08-06
EP0863878A1 (de) 1998-09-16
PT863878E (pt) 2003-04-30
DK1288203T3 (da) 2005-07-11
ZA967514B (en) 1997-03-10
ATE230731T1 (de) 2003-01-15
NO311357B1 (no) 2001-11-19
AU701989B2 (en) 1999-02-11
ATE293604T1 (de) 2005-05-15
HUP9803028A2 (hu) 1999-04-28
DK0863878T3 (da) 2003-04-22
CA2231812A1 (en) 1997-03-20
DE69625701D1 (de) 2003-02-13
ES2239194T3 (es) 2005-09-16
NO981054D0 (no) 1998-03-10
CN1250528C (zh) 2006-04-12
DE69625701T2 (de) 2003-10-02
JPH11512427A (ja) 1999-10-26
KR19990044557A (ko) 1999-06-25
HUP9803028A3 (en) 1999-05-28
EP0863878B1 (de) 2003-01-08
US5962469A (en) 1999-10-05
MX9801892A (es) 1998-05-31
PT1288203E (pt) 2005-08-31
IL123345A0 (en) 1998-09-24
AR004950A1 (es) 1999-04-07
ES2185797T3 (es) 2003-05-01
KR100512675B1 (ko) 2006-08-10
NZ316288A (en) 2000-01-28
DE69634647T2 (de) 2006-03-02
CN1196050A (zh) 1998-10-14

Similar Documents

Publication Publication Date Title
DE69612211D1 (de) Tissueprodukte die weichmacher und silikonglykol enthalten
DE69618375D1 (de) Verpackung und Vorrichtung zu deren Herstellung
DE69624910D1 (de) Orale pharmazeutische dosierungsformen die einen protonenpumpeninhibitor und ein prokinetisches mittel enthalten
DE29580137U1 (de) Zweiteilige Vorrichtung für die Verabreichung von Arzneimitteln
DE69435088D1 (de) Therapeutische und diagnostische mittel für die amyloidosis
DE69007886T2 (de) Östradiol enthaltende Mittel und Verfahren zur topischen Anwendung.
DE69720978D1 (de) Topische mittel, die eine öl-in-wasser emulsion und ein retinoid enthalten
DE69521799D1 (de) Polymer umhüllte tablette enthaltend amoxicillin und clavulanat
DE69302257D1 (de) Pilzhemmendes und hautheilungsförderndes Mittel
BR9703624A (pt) Combinação formulação farmacêutica processo para o tratamento de depressão em um animal uso de mirtazapina uso de um ou mais srri's e embalagem
DE69422130T2 (de) Osteometrie und osteometrische vorrichtung
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
DE59607535D1 (de) Kosmetische und/oder pharmazeutische zubereitungen
DK0776881T3 (da) Diaromatiske forbindelser, der bærer en adamantylgruppe i parastilling, farmaceutiske og kosmetiske præparater, der indehol
DE3889302D1 (de) 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff.
DE69513803T2 (de) Alumoxanen und katalysatore die alumoxanen enthalten
ATE293604T1 (de) Cyclische nitrone und pharmazeutische mittel die sie enthalten
PT86572A (de) Polymer-komplexe verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
PT95656A (pt) Dispositivo de dupla extremidade para aplicacao e medicao de drogas
DE69631402D1 (de) Polymermischungen die Polyoxaestern und Lactonpolymeren enthalten
ATA67488A (de) Immunglobulinkonjugate, verfahren zu deren herstellung und anwendung sowie pharmazeutische mittel, die diese enthalten
DE69513225T2 (de) Insektizide und akarizide Mittel
DE69231238T2 (de) Cyclische Nitrone, ihre Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
BR9606066A (pt) Composto e formulação farmacêutica
DE29622895U1 (de) Polsterkörper und Vorrichtung zu seiner Herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8339 Ceased/non-payment of the annual fee